Publicaciones en las que colabora con Adrián Sousa Dominguez (15)

2024

  1. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

2023

  1. Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

    Annals of Clinical Microbiology and Antimicrobials, Vol. 22, Núm. 1

  2. Impact of Methylprednisolone Pulse on the Mortality of Patients With Acute Respiratory Distress Syndrome Secondary to COVID-19

    Infectious Diseases in Clinical Practice, Vol. 31, Núm. 6

2022

  1. Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 9, pp. 1173-1182

  2. Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 12, pp. 1399-1405

  3. Successful ceftazidime–avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis

    Infection

2021

  1. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 445-450

  2. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia

    Medicine, Vol. 100, Núm. 14, pp. e24880

2019

  1. Moving beyond unsolicited consultation: Additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 4, pp. 1101-1107

  2. Short- versus long-course therapy in gram-negative bacilli bloodstream infections

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 5, pp. 851-857

  3. Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a β-lactamase producing organism

    Infectious Diseases, Vol. 51, Núm. 1, pp. 32-37

2018

  1. Clinical and microbiological characteristics of unusual manifestations of invasive pneumococcal disease

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 5, pp. 284-289

  2. Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 3170-3175

2017

  1. Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam

    Journal of Antimicrobial Chemotherapy

2016

  1. Guía de tratamiento empírico de las infecciones más habituales del adulto en Atención Primaria

    Cadernos de atención primaria, Vol. 22, Núm. 0, pp. 33-34